Since these early experiments, other investigators have shown similar results supporting the use of MV-NIS as an imaging reporter in oncolytic viral therapy studies of ovarian cancer, pancreatic cancer, prostate cancer, and mesothelioma [88, 103, 122-124]. The gene discussed is SLC5A5; the disease is prostate cancer.